Sort
30,917 grants matching “tumor microenvironment”
Bitter Melon Component and Colon Cancer Prevention
$544,710Shrikant Anant · University Of Kansas Medical Center · R01 · FY2017 · CA
Bitter Melon Component and Colon Cancer Prevention
$544,710Shrikant Anant · University Of Kansas Medical Center · R01 · FY2016 · CA
Training Program in Basic Cancer Research
$544,673Maureen E Murphy · Wistar Institute · T32 · FY2019 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
$544,659Chi V. Dang · Johns Hopkins University · R01 · FY2023 · CA
Functional Relevance of Pyrimidine Sensing and Response Pathways in Tumor Metabolism and Cancer Therapy
$544,658Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2024 · CA
Functional Relevance of Pyrimidine Sensing and Response Pathways in Tumor Metabolism and Cancer Therapy
$544,658Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2025 · CA
MRI Radiomic Signatures of DCIS to Optimize Treatment
$544,651Habibollah Rahbar · University Of Washington · R01 · FY2024 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$544,635Amy E Moran · Oregon Health & Science University · R37 · FY2022 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$544,635Amy E Moran · Oregon Health & Science University · R37 · FY2025 · CA
Project 2
$544,481Paolo Provenzano · University Of Minnesota · P01 · FY2022 · CA
Project 2
$544,481Paolo Provenzano · University Of Minnesota · P01 · FY2023 · CA
Decoding the metabolic routes of purine nucleotides in cancer - Resubmission - 1
$544,478Gerta N/a Hoxhaj · Ut Southwestern Medical Center · R01 · FY2025 · CA
Tissue engineered organ-specific cancer metastasis model for cancer research
$544,475Andrew Zhuang Wang · Ut Southwestern Medical Center · R01 · FY2025 · CA
Tissue engineered organ-specific cancer metastasis model for cancer research
$544,475Andrew Zhuang Wang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Combine mitochondrial gene therapy and synthetic lethal chemotherapy to treat triple-negative breast cancer
$544,425Xiaoguang Margaret Liu · Ohio State University · R01 · FY2024 · CA
Influences of the Microenvironment on Cancer Stem Cells
$544,406Hong Wu · University Of California Los Angeles · U01 · FY2013 · CA
Artificial, Humanized Stem Cell Niches
$544,399Biju Parekkadan · Rutgers, The State Univ Of N.J. · R01 · FY2019 · EB
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$544,399Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2021 · DK
Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients
$544,375James M Olson · Presage Biosciences, Inc. · R42 · FY2011 · CA
CLINICAL THERAPY TRIALS
$544,224Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2007 · CA
Targeting MTOR signaling in pancreatic cancer
$544,134Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy
$544,131Weiqiang Chen · New York University · R01 · FY2020 · CA
MRI and blood biomarkers of neoadjuvant therapy response and outcomes in rectal cancer
$544,093Ruijiang Li · Stanford University · R01 · FY2025 · CA
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
$544,076Nimmi Ramanujam · Duke University · R01 · FY2019 · EB
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$544,035Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA